Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
C 39.05 -1.41% -0.56
PFE closed down 1.41 percent on Wednesday, June 23, 2021, on 87 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical PFE trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Cup with Handle Other 0.00%
20 DMA Support Bullish -1.41%
Cup with Handle Other -1.41%
NR7 Range Contraction -1.41%
Crossed Above 20 DMA Bullish -0.94%
Crossed Above 50 DMA Bullish -0.94%
Cup with Handle Other -0.94%
Older End-of-Day Signals for PFE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits about 4 hours ago
Down 1 ATR about 15 hours ago
50 DMA Support about 18 hours ago
20 DMA Support about 18 hours ago
Down 1% about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pfizer, Inc. Description

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Biopharmaceutical Pharmaceutical Industry Pain Disease Clinics Pharmaceutical Products Medication Inflammation Neuroscience Hypertension Alzheimer's Disease Animal Health Dysfunction Ophthalmology Pain Management Dietary Supplements Pulmonary Arterial Hypertension Dietary Supplement Major Depressive Disorder Depressive Disorder Primary Care Glaxosmithkline Hemophilia Smoking Smoking Cessation Anti Infectives Prescription Product Prescription Products Endocrine Disorders Livestock Producers Cardiovascular Erectile Dysfunction Genitourinary

Is PFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 43.08
52 Week Low 31.61
Average Volume 25,175,697
200-Day Moving Average 37.24
50-Day Moving Average 39.26
20-Day Moving Average 39.25
10-Day Moving Average 39.57
Average True Range 0.63
ADX 15.6
+DI 21.41
-DI 23.09
Chandelier Exit (Long, 3 ATRs) 38.82
Chandelier Exit (Short, 3 ATRs) 40.38
Upper Bollinger Bands 40.32
Lower Bollinger Band 38.19
Percent B (%b) 0.4
BandWidth 5.44
MACD Line 0.06
MACD Signal Line 0.13
MACD Histogram -0.063
Fundamentals Value
Market Cap 217.06 Billion
Num Shares 5.56 Billion
EPS 1.54
Price-to-Earnings (P/E) Ratio 25.39
Price-to-Sales 4.22
Price-to-Book 3.11
PEG Ratio 5.22
Dividend 1.52
Dividend Yield 3.89%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.08
Resistance 3 (R3) 40.17 39.91 39.91
Resistance 2 (R2) 39.91 39.65 39.87 39.85
Resistance 1 (R1) 39.48 39.49 39.36 39.39 39.79
Pivot Point 39.23 39.23 39.17 39.18 39.23
Support 1 (S1) 38.80 38.97 38.67 38.71 38.31
Support 2 (S2) 38.54 38.81 38.50 38.25
Support 3 (S3) 38.11 38.54 38.19
Support 4 (S4) 38.02